What is the significance of TRNT1 (Tyrptophanyl-tRNA synthetase 1)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The anti-Jo-1 antibody is the most common myositis-specific autoantibody, found in approximately 20% of adult patients with idiopathic inflammatory myopathy (IIM) 1. When evaluating patients with IIM, it is essential to consider the clinical associations and frequencies of various myositis-specific autoantibodies.

  • The anti-synthetase antibodies, including Jo-1, PL-7, PL-12, OJ, EJ, KS, Ha, and Zo, are associated with distinct clinical features such as mechanic’s hands, arthritis, Raynaud phenomenon, interstitial lung disease (ILD), and myositis 1.
  • The anti-Mi2 antibody is associated with classic cutaneous features of dermatomyositis, including Gottron papules, shawl sign, cuticle overgrowth, V-sign, and heliotrope rash 1.
  • The anti-SRP antibody is directed against the signal recognition particle and is associated with necrotizing myopathy, acute in onset, with dilated cardiomyopathy and a poor response to standard immunosuppression 1. In clinical practice, identifying the specific myositis-specific autoantibody present in a patient can help guide treatment decisions and predict disease course.
  • For example, patients with anti-Jo-1 antibody may require more aggressive treatment for ILD and arthritis, while those with anti-SRP antibody may require more intensive immunosuppression due to the poor response to standard therapy 1. Overall, understanding the clinical associations and frequencies of myositis-specific autoantibodies is crucial for providing optimal care for patients with IIM.

From the Research

TRNT1 Overview

  • TRNT1 (CCA-adding transfer RNA nucleotidyl transferase) enzyme deficiency is a metabolic disease caused by defective post-transcriptional modification of mitochondrial and cytosolic transfer RNAs (tRNAs) 2
  • The disease is characterized by infantile-onset cyclical, aseptic febrile episodes with vomiting and diarrhea, global electrolyte imbalance, sideroblastic anemia, B lymphocyte immunodeficiency, retinitis pigmentosa, hepatosplenomegaly, exocrine pancreatic insufficiency, and renal tubulopathy 2
  • TRNT1 mutations can cause a spectrum of disease ranging from a childhood-onset complex disease with manifestations in most organs to an adult-onset isolated retinitis pigmentosa presentation 2, 3

Clinical Features and Management

  • Clinical features of TRNT1 deficiency include sensorineural deafness, cerebellar atrophy, brittle hair, partial villous atrophy, and nephrocalcinosis 2
  • Acute management of TRNT1 deficiency includes transfusion for anemia, fluid and electrolyte replacement, and immunoglobulin therapy 2
  • Bone marrow transplantation has been shown to resolve fever and reverse the abnormal metabolic profile in one patient 2

Relationship to Other Conditions

  • There is no direct relationship between TRNT1 and paracetamol (acetaminophen) in the provided studies 4, 2, 3, 5, 6
  • Paracetamol is a widely used drug for fever and acute pain, but its mechanism of action is not fully understood 4
  • TRNT1 is associated with various diseases, including sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD), retinitis pigmentosa with erythrocyte microcytosis, and progressive B-cell immunodeficiency 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diseases Associated with Defects in tRNA CCA Addition.

International journal of molecular sciences, 2020

Research

Acetaminophen for Chronic Pain: A Systematic Review on Efficacy.

Basic & clinical pharmacology & toxicology, 2016

Research

Acetaminophen.

Annals of internal medicine, 1977

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.